Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate.
We recently described a new, live-attenuated vaccine candidate for chikungunya (CHIK) fever, CHIKV/IRES. This vaccine was shown to be well attenuated, immunogenic and efficacious in protecting against CHIK virus (CHIKV) challenge of mice and nonhuman primates. To further evaluate its preclinical saf...
Saved in:
Main Authors: | Kenneth S Plante (Author), Shannan L Rossi (Author), Nicholas A Bergren (Author), Robert L Seymour (Author), Scott C Weaver (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2015-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel live-attenuated vaccine candidate for mayaro Fever.
by: William J Weise, et al.
Published: (2014) -
IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.
by: Mathilde Guerbois, et al.
Published: (2013) -
A Rodent Model of Chikungunya Virus Infection in RAG1 -/- Mice, with Features of Persistence, for Vaccine Safety Evaluation.
by: Robert L Seymour, et al.
Published: (2015) -
Chikungunya Vaccine Candidates: Current Landscape and Future Prospects
by: Schmidt C, et al.
Published: (2022) -
Preclinical evaluation of the immunogenicity and safety of an inactivated enterovirus 71 candidate vaccine.
by: Shi-Hsia Hwa, et al.
Published: (2013)